Sabinsa’s Curcumin C3 Reduct now self-affirmed GRAS
Sabinsa’s patented color-free Curcumin C3 Reduct has been found to meet the criteria to be considered Generally Recognized as Safe (GRAS) following a comprehensive review of safety and toxicology data.
Image courtesy of Sabinsa
Sabinsa’s patented color-free Curcumin C3 Reduct tetrahydrocurcuminoids, a metabolite of curcumin, has been found to meet the criteria to be considered Generally Recognized as Safe (GRAS) following a comprehensive review of safety and toxicology data by an independent panel of scientists convened by Soni & Associates Inc. The ingredient is designed to deliver the benefits of Curcumin C3 Complex without the vivid color inherent in turmeric extracts.
“The panel considered that the available qualitative and quantitative scientific evidence, including human and animal data, to be sufficient to establish the safety of C3 Reduct at maximum levels for various foods and beverages, resulting in the 90th percentile all-user estimated intake of 239.20 mg/person/day,” explained Madhusudan Soni Ph.D., in a press release. “The safety assessment to ascertain GRAS status for C3 Reduct for the specified food uses meets FDA criteria for reasonable certainty of no harm by considering both the technical and common knowledge elements.”
Kaneka Nutrients to unveil new consumer research on menopausal women at Vitafoods Europe 2024
April 26th 2024The company will reveal the results of the research that is based on live feedback from 200 menopausal women who took 200 mg per day of Kaneka Ubiquinol over two-months, monitored the effects, and recorded their observations.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
